Chong Kun Dang Pharmaceutical Corp.

Informe acción KOSE:A185750

Capitalización de mercado: ₩1.4t

Chong Kun Dang Pharmaceutical Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Young-Joo Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO3.3yrs
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

May 27
Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly

A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Apr 09
A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Apr 19
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Apr 05
Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock

Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Mar 09
Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?

Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

Feb 24
Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Feb 11
The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It

Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Jan 27
Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?

Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

Jan 12
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?

With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

Dec 28
With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting

What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Dec 09
What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?

Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

Nov 24
Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?

CEO

Young-Joo Kim

3.3yrs

Permanencia

Mr. Young-Joo Kim serves as the President, Chief Executive Officer and Director of Chong Kun Dang Pharmaceutical Corp. and serves as its Chairman since March 26, 2021.

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Young-Joo Kim
President3.3yrssin datossin datos
Hong-Bae Kim
Full-Time Auditor4.3yrssin datossin datos
In-Su Kang
Independent Outside Director5.3yrssin datossin datos
Dong-ha Lee
Directorless than a yearsin datossin datos

3.8yrs

Permanencia media

Junta con experiencia: La junta directiva de A185750 se considera experimentada (3.1 años de antigüedad promedio).